Thorsten Graef
An AbbVie clinical vet heading early oncology jumps ship to build his own team at NK cell-focused biotech
Making the leap from a mid-sized biotech into the ranks of pharma can be a chafing experience for executives used to a more flexible work …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
